Early Trial Of New Multi-kinase Inhibitor Shows Impressive Activity In Thyroid Cancer
Monday, October 27, 2008 - 09:35
in Health & Medicine
Preliminary trials of a new multi-kinase inhibitor have indicated it has impressive tumor shrinkage activity in patients with a difficult to treat type of thyroid cancer. The results have put the drug's development on a fast track, prompting the accelerated initiation of a large phase III trial.